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Introduction
Understanding the molecular mechanisms that direct the 
differentiation and connectivity of neuronal cells in the brain 
remains one of the major challenges in cell biology (Shen and 
Scheiffele, 2010; Zipursky and Sanes, 2010). Neuronal cell 
types are characterized by unique morphological and func-
tional properties that shape signal processing in neuronal net-
works (Masland, 2004; Okaty et al., 2011). The remarkable 
diversity of neuronal properties is achieved by cell type– 
specific gene expression programs. Alternative splicing greatly 
amplifies the coding capacity of the genome and, thereby, pro-
vides a powerful mechanism controlling molecular and func-
tional diversity. For example, alternative splicing programs 
control abundance, identity, transport, and turnover of certain 
neuronal mRNAs (Darnell, 2013; Zheng and Black, 2013). 
Ultimately, these RNA regulatory mechanisms contribute to 
the control of selective cell surface interactions, ion channel 
properties, and neuronal signaling (Siddiqui et al., 2010; Beck 
et al., 2012; Gehman et al., 2012; Lipscombe et al., 2013). It is 
an attractive hypothesis that cell type–specific alternative 
splicing factors are used to shape the molecular repertoires of 
functionally and morphologically defined sub-classes of neu-
ronal cells. However, splicing factors that are linked to a ge-
netically defined subsets of neurons and that are essential to 
sculpt cell type–specific neuronal gene expression are only be-
ginning to emerge.
The KH domain–containing RNA-binding protein SAM68 
(Src-associated in mitosis of 68 kD protein, Khdrbs1) is a criti-
cal regulator of RNA transport and neuronal activity–regulated 
alternative splicing (Iijima et al., 2011; Klein et al., 2013). 
SAM68 is broadly expressed in neuronal and nonneuronal cells 
and regulates alternative splicing of Nrxn1, which encodes a 
synaptic cell surface receptor (Missler and Südhof, 1998; Dean 
et al., 2003; Craig and Kang, 2007; Südhof, 2008; Iijima et al., 
2011). Cerebellar Sam68KO neurons fail to increase exon skip-
ping at the Nrxn1 alternatively spliced segment 4 (AS4) upon 
neuronal depolarization. In wild-type neurons, this SAM68- 
dependent exon skipping results in production of NRX protein 
variants with altered ligand interactions (Boucard et al., 2005; 
Chih et al., 2006; Graf et al., 2006; Uemura et al., 2010; Iijima 
et al., 2011; Matsuda and Yuzaki, 2011; Aoto et al., 2013). Con-
sistent with an important function for SAM68 in vivo, there is a 
corresponding reduction in the skipped AS4() transcript in 
Sam68KO brains. Global ablation of the closely related RNA-
binding protein SLM2 (SAM68-like mammalian protein 2; 
alternate names: T-STAR, Khdrbs3; Di Fruscio et al., 1999; 
The unique functional properties and molecular iden­tity of neuronal cell populations rely on cell type–specific gene expression programs. Alternative 
splicing represents a powerful mechanism for expanding 
the capacity of genomes to generate molecular diversity. 
Neuronal cells exhibit particularly extensive alternative 
splicing regulation. We report a highly selective expres­
sion of the KH domain–containing splicing regulators 
SLM1 and SLM2 in the mouse brain. Conditional abla­
tion of SLM1 resulted in a severe defect in the neuronal 
isoform content of the polymorphic synaptic receptors 
neurexin­1, ­2, and ­3. Thus, cell type–specific expression 
of SLM1 provides a mechanism for shaping the molecular 
repertoires of synaptic adhesion molecules in neuronal 
populations in vivo.
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reduction in Nrxn1 AS4() transcripts as well as defects in 
cerebellar morphogenesis. Finally, we demonstrate that cell 
type–specific conditional ablation of SLM1 disrupts cell 
type–specific generation of Nrxn splice variants. Thus, SLM1 
is a critical RNA-binding protein that shapes cell type– 
specific alternative splicing programs in vivo.
Results
SLM1 and SLM2 are expressed in largely 
segregated neuronal populations
Western blotting analysis of different mouse brain areas with 
SAM68, SLM1, and SLM2 antibodies indicates that these pro-
teins are detectable across all brain regions examined (Fig. S1 A). 
To explore whether SLM proteins are confined to specific ana-
tomically and molecularly defined neuronal populations, we 
performed a detailed analysis using SLM1- and SLM2-specific 
antibodies. SLM1 and SLM2 were detected in largely non-
overlapping cell populations, whereas SAM68 is more widely 
expressed (Fig. 1 A; Fig. S1, B and C). In the cortex, SLM1 marks 
Venables et al., 1999) also results in a reduction in exon skip-
ping at Nrxn AS4, which correlates with the regional expres-
sion levels of SLM2 in the brain (Ehrmann et al., 2013). These 
studies established SAM68 and SLM2 in alternative splicing 
regulation in the mouse brain. However, it is not known 
whether the activity of these proteins is essential to generate 
cell type–specific gene expression programs in defined neuro-
nal cell populations.
In this work, we uncover that SLM2 and the closely re-
lated SLM1 are expressed in highly selective and largely 
nonoverlapping populations of neurons in the central ner-
vous system of mice. In the hippocampus, SLM1 is abundant 
in glutamatergic dentate granule cells but also in a specific 
set of cholecystokinin–calbindin double-positive (CCK+ cal-
bindin+) inhibitory interneurons. By contrast, SLM2 is confined 
to glutamatergic pyramidal cells and GABAergic parvalbu-
min+, calretinin+, and somatostatin+ interneurons. We dem-
onstrate that SLM1 differs from SAM68 in its ability to 
regulate alternative splicing of different Nrxn mRNAs at AS4 
in vitro. Slm1KO mice and Sam68:Slm1DKO exhibit a severe 
Figure 1. Differential distribution of SLM1 and SLM2 proteins in the mouse brain. (A) Gross expression patterns of STAR family proteins in adult brain. Cx, 
cortex; Hp, hippocampus; Str, striatum; Th, thalamus; Mb, midbrain; Cb, cerebellum; Bs, brain stem. Bar, 1 mm. (B) High magnification images of SLM 
expression in various brain areas. I–III, cortical layer I–III; M.L., molecular layer; P.C.L., Purkinje cell layer; G.L., granular layer. S.O., stratum oriens; S.P., 
stratum pyramidale; S.R., stratum radiatum. Hi, hilus. Bar, 50 µm.
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SLM1 (Fig. 2, E and F). SLM1 was largely absent from cal-
retinin+, vasoactive intestinal peptide (VIP)+, parvalbumin+, 
and somatostatin+ interneurons. Calbindin and CCK immuno-
reactivity overlap in two specific interneuron populations in 
S.R./S.L.M. designated Schaffer collateral–associated (SCA) 
interneurons and perforant path–associated (PPA) interneu-
rons (Lawrence, 2008; Klausberger, 2009). Interestingly, 93% 
of these CCK/calbindin double-positive interneurons showed 
SLM1 immunoreactivity. These results identify SCA inter-
neurons and PPA interneurons as a major site of SLM1 ex-
pression (Fig. 2 F; Fig. S2 C). Calbindin and CCK-positive 
interneurons largely lack detectable SLM2 immunoreactiv-
ity, which instead was observed in the vast majority (>90%) 
of calretinin and VIP-positive interneurons in S.R. and 
S.L.M. Moreover, in stratum oriens (S.O.) SLM2 was highly 
expressed in parvalbumin+ and somatostatin+ interneurons 
(Fig. 2, E and F). These experiments uncover a striking non-
overlapping distribution of SLM1 and SLM2 in vivo. The 
quantitative analysis with cell type–specific markers demon-
strates that the respective SLM1- and SLM2-positive cell 
populations are not due to stochastic expression or detection 
of the proteins in subsets of cells. By contrast, expression is 
tightly linked to molecularly defined cell identity. Thus, 
SLM1 and -2 are well suited to regulate neuronal alternative 
splicing programs in a cell type–specific manner.
a sparse population of cells in layers 2–3 and layer 5, whereas 
SLM2 is expressed in the majority of NeuN-positive cortical 
cells (Fig. 1 B; unpublished data). By contrast, SLM2 is largely 
absent from midbrain neurons of the superior and inferior col-
liculus where the majority of cells express SLM1 (Fig. 1 B). In 
the cerebellum, SLM1 is highly concentrated in Purkinje cells, 
whereas SLM2 marks interneurons in the inner granular and 
molecular layer. Thus, SLM1 and SLM2 are restricted to sub-
populations of neurons in the mouse brain.
A particularly interesting segregation of SLM1 and -2 
is seen in the mature hippocampus. In principal cells, SLM2 
is detectable exclusively in CA neurons, whereas SLM1 is 
highly expressed in dentate granule cells (Fig. 1 B; Fig. S2 
A; Stoss et al., 2004). Notably, both proteins are also highly 
expressed in nonoverlapping populations of inhibitory inter-
neurons (Fig. S2 B). SLM2 is concentrated in interneurons in 
the hilus (Fig. 1 B, dentate gyrus; Fig. S2 A). Within area 
CA1, the majority of SLM1-positive (SLM1+) cells are lo-
cated in stratum radiatum (S.R.) and its border to the stratum 
lacunosum moleculare (S.L.M.; Fig. 2, A–C). We applied a 
combination of interneuron markers to directly define this 
population. 43% of all SLM1+ cells were marked with the 
interneuron marker calbindin and 54% were immuno-positive 
for CCK (Fig. 2 D). Conversely, 70% of all calbindin+ and 
70% of all CCK+ interneurons in S.R. and S.L.M. expressed 
Figure 2. Hippocampal interneuron subclass-specific expression of SLM1 and SLM2. (A) Schematic illustration of expression of SLM proteins in principal 
cells of the hippocampal area. (B) SLM1-positive interneurons in hippocampal area CA1. Bar, 100 µm. S.R., stratum radiatum; S.L.M., stratum lacunosum 
moleculare; S.P., stratum pyramidale; S.O., stratum oriens. (C) Distribution of SLM1-positive interneurons in CA1. The percentage of SLM1+ cells that are 
located in each stratum was quantified. (D) Percentage of SLM1-positive interneurons that are immuno-positive for various inhibitory interneuron mark-
ers within stratum radiatum and stratum lacunosum moleculare of CA1 (right; n = 3 animals). (E) Mutually exclusive expression of SLM1 and SLM2 in 
hippocampal interneurons immuno-positive for calbindin (CB), calretinin (CR), parvalbumin (PV), and somatostatin (SOM). Coronal sections (from 2–3-mo-old 
mice) were co-immunostained with anti-SLM antibodies and inhibitory interneuron markers. Bar, 20 µm. (F) Fraction of SLM1- and SLM2-positive cells within 
immunohistochemically defined inhibitory interneuron populations in area CA1 (n = 3 animals).  o
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Figure 3. Function of SLM proteins in Nrxn1, Nrxn2, and Nrxn3 alternative splicing regulation in vitro. (A) Splice reporters for Nrxn1, Nrxn2, and Nrxn3 
AS4. Nrxn splice reporter constructs contain AS4 with constitutive exons (dark gray), alternative exon 20 (light gray), and introns shown as lines. Intron 
sizes are indicated (drawings not to scale). (B) Splice reporter assays with various RNA-binding proteins. Reporter expression vectors were cotransfected 
into HEK293T cells with epitope-tagged expression constructs for GFP-SAM68, GFP-SLM1, GFP-SLM2, YFP-hnRNPA1, or YFP-hnRNPH1. Alternative splice 
isoform choice was measured by semi-quantitative RT-PCR with primers flanking the alternatively spliced segment. Fragment sizes for AS4(+) and AS4() 
isoforms are 318 bp and 228 bp (Nrxn1), 270 bp and 180 bp (Nrxn2), and 354 bp and 264 bp (Nrxn3). Expression of transfected RNA-binding proteins 
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(Fig. 4 B). To further explore complex formation in brain tissue 
we performed coimmunoprecipitation experiments for the en-
dogenous proteins and observed robust, RNA-independent as-
sociation between SAM68 and SLM1 but not SLM2 (Fig. 4 C). 
Given that STAR proteins are thought to function as oligomers 
that bind to bi-partite RNA motifs (Galarneau and Richard, 
2009; Meyer et al., 2010), we examined whether SAM68–SLM1 
complex formation would alter activity toward Nrxn2. Co- 
expression of increasing amounts of SAM68 progressively inhib-
ited the activity of SLM1 toward Nrxn2 AS4 without modifying 
the activity toward Nrxn1 (Fig. 4 D). In the same assay, SAM68 
was much less potent in inhibiting SLM2 activity toward Nrxn2 
(Fig. 4 D), consistent with a preferential complex formation be-
tween SAM68 and SLM1. Thus, substrate specificity of STAR 
family proteins can be modulated by hetero-oligomer formation.
Anatomical alterations in Slm1KO and 
Sam68:Slm1DKO mice
To explore functions of SLM1 in vivo we generated a condi-
tional Slm1 allele in mice. Exon 2 of the Khdrbs2 gene (which 
encodes SLM1) was flanked by loxP sites (Fig. S3 A). Global 
Slm1KO mice were subsequently generated by Cre-mediated re-
combination in the germline. Homozygous Slm1KO mice com-
pletely lacked SLM1 protein expression but did not show 
detectable alterations in SAM68 or SLM2 expression levels 
(Fig. 5, A–C). Knockout animals were born at Mendelian fre-
quencies, were viable and fertile, and did not exhibit any obvi-
ous behavioral alterations (Fig. 5 D). An anatomical survey of 
adult Slm1KO brains did not reveal any gross anatomical defects 
(Fig. 5 A). Given that SAM68 and SLM1 have overlapping sub-
strates and are largely coexpressed in neuronal populations, we 
further generated Sam68:Slm1 double-knockout mice (Sam68:
Slm1DKO). These animals were viable but not fertile (consistent 
with the previously reported function for SAM68 in reproduc-
tion). We did not detect major alterations in the distribution 
of synaptic markers in the hippocampus or cerebellum of the 
double-knockout mice (Fig. S3, B and C). However, Sam68:
Slm1DKO mice had slightly smaller brains than wild-type animals 
and cerebella of Slm1KO and Sam68:Slm1DKO were significantly 
reduced in weight (Fig. 5 E). Interestingly, the cerebella of 
Sam68:Slm1DKO exhibited a defect in foliation with loss of the 
cerebellar fissure separating lobules VIb and VII (Fig. 5 F, pheno-
type observed in four out of four Sam68:Slm1DKO animals but 
none of their single-knockout littermates or wild-type controls). 
This defect was not observed in either single-knockout model, 
although the depth of the fissure was slightly reduced in 
Sam68KO mice (Fig. 5 G). These findings demonstrate a redun-
dant function of Slm1 and Sam68 in cerebellar morphogenesis. 
Within the fused region of lobules VIb and VII the Purkinje cell 
layer was disorganized, with ectopic Purkinje cells scattered in 
SLM1 regulates Nrxn2 alternative splice 
reporters in heterologous cells
In previous work we demonstrated that SAM68, SLM1, and 
SLM2 can regulate Nrxn1 splice reporters (“mini-genes”) when 
transfected into human embryonic kidney cells (HEK293; 
Iijima et al., 2011). Given the highly selective expression of 
SLM1, we asked whether its ability to regulate mRNA targets 
might differ from SAM68. When SAM68, SLM1, and SLM2 
activity toward Nrxn1, Nrxn2, and Nrxn3 splice reporters was 
analyzed in HEK293 cells we observed that all three proteins 
could efficiently drive exon skipping at Nrxn1 and Nrxn3 AS4. 
Importantly, SAM68 did not exhibit significant activity toward 
a Nrxn2 AS4 reporter, whereas SLM1 and SLM2 did induce 
exon skipping in Nrxn2 (Fig. 3, A and B). Under the same con-
ditions, hnRNPH and A1 did not show activity toward any of 
the Nrxn AS4 reporters (Fig. 3 B). The specific activity of SLM 
proteins toward Nrxn2 reporters was further confirmed in as-
says with increasing amounts of the alternative splicing factors 
(Fig. 3, C and D).
To obtain insight into the molecular underpinnings of the 
target specificity of SAM68 versus SLM1 we generated chime-
ric forms of these RNA-binding proteins (Fig. 3 E). SAM68 
differs from SLM1 and SLM2 in an extended N-terminal region 
of 96 amino acids that is absent in the SLM proteins. Fusion of 
this N-terminal domain to SLM1 did not alter its ability to regu-
late Nrxn2, indicating that this domain is not sufficient to abol-
ish alternative splicing regulation toward Nrxn2 (Fig. 3 F). 
Replacement of the SLM1 RNA-binding domain with corre-
sponding sequences from SAM68 rendered this protein inactive 
toward Nrxn2. By contrast, replacement of the C-terminal do-
main with SAM68 sequences did not modify activity toward 
Nrxn2. Importantly, all chimeric proteins retained activity to-
ward processing of the Nrxn1 reporter, thereby confirming ap-
propriate folding and subcellular targeting of the chimeric 
proteins (Fig. 3 F). These experiments demonstrate that SLM1 
differs from SAM68 in that it exhibits activity toward Nrxn2 
and that this activity arises from specific sequences in the SLM1 
RNA-binding domain.
Co-expression and complex formation of 
SLM1 and SAM68
Whereas SLM1 and SLM2 expression are largely segregated at 
the cellular level, SLM1 and SAM68 are coexpressed in indi-
vidual cells (note that given the broad distribution of SAM68 
also most SLM2-positive cells co-express SAM68; Fig. 4 A; 
Fig. 1 A; unpublished data). Previous in vitro studies demon-
strated that SLM1 and SAM68 form protein complexes that 
are not detected for SLM2 (Di Fruscio et al., 1999; Rajan 
et al., 2009). We confirmed SAM68–SLM1 association in co-
immunoprecipitation experiments from transfected HEK293 cells 
was confirmed by Western blotting with anti-GFP antibodies. (C) Dose-dependent activity of STAR family proteins toward Nrxn, Nrxn2, and Nrxn3 AS4. 
Splice reporter processing was assessed in experiments with increasing amounts of DNA encoding RNA-binding proteins transfected (DNA amounts used 
indicated in micrograms). (D) Alternative splicing was assayed by semi-quantitative RT-PCR. Expression levels of GFP-tagged proteins were detected by 
immunoblot. (E) Schematic drawing of domain organization of SAM68 and SLM1 and chimeric mutants proteins. An HA-tag was attached to the C-terminal 
end of each open reading frame. (F) Splice reporter assays with chimeric proteins using Nrxn1 and Nrxn2 AS4 reporters. Alternative splicing was assayed 
by semi-quantitative RT-PCR. Expression of the HA-tagged proteins was confirmed by immunoblotting.
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the Sam68:Slm1DKO mice. This functional antagonism between 
SAM68 and SLM1 in vivo was surprising, as both proteins 
show similar activity toward a Nrxn3 AS4 reporter in heterolo-
gous cells (Fig. 3). Thus, our Sam68:Slm1DKO analysis reveals 
an unanticipated gene-specific interplay of SAM68 and SLM1 
functions in the alternative splicing regulation of Nrxn3.
Cell type–specific disruption of Nrxn 
alternative splicing
The SLM1 expression pattern suggests that SLM1 may regulate 
cell type–specific alternative splicing programs. We hypothe-
sized that presence of SLM1 in a neuronal cell population might 
instruct Nrxn1 isoform choice. To test this, we mis-expressed 
SLM1 in cultured cerebellar cells, a largely homogeneous pop-
ulation of granule cells that lacks detectable SLM1 expression 
and shows predominant expression of Nrxn AS4(+) isoforms. 
Introduction of SLM1 into granule cells was sufficient to stimu-
late exon skipping and up-regulation of AS4() isoforms in 
Nrxn1,2,3 (Fig. 7 A). Thus, in this cellular context, SLM1 is 
sufficient to drive formation of AS4() isoforms.
Although the global Slm1KO analysis is consistent with 
a requirement for SLM1 in AS4() isoform choice in vivo, this 
analysis does not allow for conclusions about cell-autonomous 
function that dictates the molecular repertoire of a defined 
cell population. To address this issue, we generated condi-
tional knockout mice (Slm1cKO) where SLM1 is ablated in 
Purkinje cells (Slm1flox/flox:: Pcp2cre; Fig. 7 B; Fig. S4). Note that 
SLM1 remains expressed in a subset of Purkinje cells, in partic-
ular in the caudal cerebellum, consistent with the heterogeneity 
the molecular layer (Fig. 5 H). SLM1 is highly expressed in 
Purkinje cells. Thus, the foliation phenotype most likely originates 
from a specific developmental deficit in this cell population.
Cooperation of SAM68 and SLM1 in 
alternative splicing regulation in vivo
Considering the overlapping functions of SAM68 and SLM1 in 
the alternative splicing regulation of Nrxn1 and in cerebellar 
morphogenesis, we explored whether alternative splicing was 
modified in Slm1KO and Sam68:Slm1DKO mice. In Slm1KO brains, 
we detected a 70% reduction of the Nrxn1 AS4() isoforms in 
midbrain, an area with particularly broad SLM1 expression 
(Fig. 6, A and B). In the cortex, where only a small sub-population 
of neurons are SLM1-positive, no significant global change in 
Nrxn1 AS4() abundance was detected (Fig. 6, B and C). Nota-
bly, in the midbrain of Sam68:Slm1DKO mice exon skipping at 
AS4 was severely reduced, demonstrating that SAM68 and 
SLM1 have synergistic functions in Nrxn1 alternative splicing 
regulation in vivo. By contrast, Nrxn2 alternative splicing at 
AS4 was not altered in the midbrain of Sam68KO mice but selec-
tively disrupted in Slm1KO mice (Fig. 6, B and C), consistent 
with the differential activity of SAM68 and SLM1 toward Nrxn2 
observed in our cellular assays. Finally, we explored alternative 
splicing at Nrxn3 AS4 in the midbrain of single- and double-
knockout mice. In Slm1KO brains skipping of the alternative 
exon at AS4 was significantly reduced, consistent with a critical 
function for SLM1 protein in suppressing incorporation of this 
alternative exon. By contrast, Sam68KO mice exhibit a substan-
tial increase in Nrxn3 AS4 skipping, which was suppressed in 
Figure 4. Different regulation of STAR proteins in alternative splicing regulation in vitro. (A) Co-expression of SAM68 and SLM1 in vivo. SAM68 and 
SLM1 proteins are detected coexpressed in a subset of midbrain neurons in the adult mouse brain. Bar, 20 µm. (B) Co-immunoprecipitation of HA-tagged 
SAM68 and GFP-tagged SAM68, SLM1, or SLM2 from HEK293 cells cotransfected with expression constructs. Immunoprecipitation was performed with 
the anti-HA antibody and proteins in input or immunoprecipitates were detected with anti-HA or anti-GFP antibodies. (C) Complex formation of SAM68 
and SLM1 in brain extracts. Complexes were precipitated with either anti-SAM68 (left) or anti-SLM2 (right) antibodies and precipitates probed with anti-
SAM68, anti-SLM1, or anti-SLM2 antibodies. When indicated, lysates were treated with Ribonuclease A before antibody addition to eliminate interactions 
that depend on integrity of cellular RNAs. (D) Alternative splicing of Nrxn1 and Nrxn2 AS4 was assayed by semi-quantitative RT-PCR. To confirm protein 
expression levels, the lysates of HEK293 cells expressing GFP-SLM1 or GFP-SLM2 and increasing amounts of GFP-SAM68 were subjected to the immuno-
blotting. Quantitation of alternative splice isoform choice is displayed on the right.
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Figure 5. Generation of Slm1KO and Sam68:Slm1DKO mice. (A) Immunohistochemistry on para-sagittal sections reveals loss of SLM1 immunoreactivity 
in Slm1KO tissue. Bar, 1 mm. (B) High magnification images of immunohistochemistry with anti-SLM1 (red), anti-NeuN (green), and anti-calbindin (blue) 
antibodies shows loss of SLM1 immunoreactivity from cerebellar Purkinje cells. Bar, 50 µm. (C) Immunoblot analysis for SAM68, SLM1, and SLM2 in total 
brain lysates demonstrates loss of anti-SLM1 immunoreactivity in Slm1KO tissue. (D) Slm1KO mice are born at Mendelian frequencies (50 pups from 4 litters). 
(E) Weight of whole brains and cerebella from wild-type, Slm1KO, and Sam68:Slm1DKO. Brain tissues from adult animals were analyzed (n = 3–4 animals 
per genotype). (F) Cerebellar foliation defect of Sam68:Slm1DKO. Para-sagittal sections of cerebellar vermis from wild-type, Slm1KO, and Sam68:Slm1DKO 
were stained with anti-calbindin antibody to visualize cerebellar foliation. Bar, 1 mm. (G) High magnification images of fissure between lobule VIb and 
lobule VII in F. Bar, 100 µm. (H) Co-immunohistochemistry with anti-RORalpha (red) and anti-calbindin (green) antibodies in cerebellar lobule VI revealed 
abnormal alignment of cerebellar Purkinje cell bodies. Bar, 50 µm.
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Figure 6. Alternative splicing defects in SLM1KO mice. (A) Incorporation of alternative exons at AS3, -4, and -5 in midbrain cDNA samples was probed 
by semi-quantitative PCR with primers flanking the insertion site and analyzed by gel electrophoresis. (B) Representative images of semi-quantitative 
RT-PCR with Nrxn AS4 performed on cortex, midbrain, and brainstem from wild-type, Slm1KO, Sam68:Slm1DKO, and Sam68KO mice. (C) Quantitative RT-PCR 
performed on cortex and midbrain cDNA samples from wild-type, Slm1KO, Sam68:Slm1DKO, and Sam68KO mice (n = 3 animals per genotype).
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or nonneuronal cells. By contrast, RNA-binding proteins that drive 
the unique expression patterns of neuronal sub-populations, such 
as specific interneuron classes, are less well understood.
Role for SLM1 in the generation of neuron-
specific molecular repertoires
In this study we demonstrate that ectopic expression of SLM1 
in a neuronal population that normally is SLM1 deficient is suf-
ficient to trigger production of specific neurexin splice variants. 
Moreover, conditional knock-out of SLM1 in an SLM-1–positive 
specific cell type results in a severe loss of specific neurexin 
splice variants in the cerebellum in vivo. This cell type–specific 
ablation of SLM1 also provides evidence that the lost splice 
variants were indeed selectively expressed in the cerebellar Pur-
kinje cells. Therefore, our results begin to unravel cell type–
specific neurexin isoform repertoires in neuronal populations 
in vivo. In the hippocampus, SLM1 is highly expressed in SCA 
and PPA interneurons. This class of GABAergic cells innervates 
CA1 pyramidal cell dendrites in the S.R. and is subject to spe-
cific forms of neuromodulatory regulation (Lawrence, 2008; 
Klausberger, 2009). In analogy to our findings in cerebellar 
neurons, we propose that selective expression of SLM1 drives a 
corresponding program of cell type–specific alternative splicing 
events in the hippocampus.
in the activity of the cre driver (Saito et al., 2005). Importantly, 
analysis of cerebellar RNA from Slm1cKO mice reveals a se-
vere reduction in the Nrxn1 AS4() mRNA, whereas total 
Nrxn1 mRNA levels are unchanged (Fig. 7, C and D). Thus, 
the vast majority of Nrxn1 AS4() and Nrxn2 AS4() iso-
forms in the cerebellum is derived from Purkinje cells where 
their expression depends on a cell-autonomous function of 
SLM1. Global ablation of SLM1 did not result in a signifi-
cant further reduction of Nrxn1 AS4() levels, consistent 
with the conclusion that SLM1 functions specifically in Pur-
kinje cells. Similarly, Nrxn2 AS4() was significantly re-
duced in Slm1cKO and Slm1KO mice (Fig. 7, C and D), further 
confirming a critical function of SLM1 in alternative splicing 
of Nrxn2 mRNA in vivo.
Discussion
Previous work has led to the identification of several families of 
neuronal RNA-regulatory proteins, including neuro-oncological 
ventral antigen (Nova-1, -2), neural poly-pyrimidine tract binding 
protein (nPTBP), and ELAV family proteins (CELFs), which 
regulate alternative exons in neuronal tissues (Darnell, 2013; 
Kuroyanagi et al., 2013). These factors direct generation of neuron- 
specific splice variants that are absent from neuronal precursor 
Figure 7. Cell type–specific alternative splicing of SLM1. (A) Shift in alternative splicing at Nrxn1, Nrxn2, and Nrxn3 AS4 in cerebellar granule cells 
expressing SLM1 ectopically with lentiviral infection. Expression of 2A-tagged SLM1 in lentivirus-infected cerebellar granule cells was confirmed by im-
munostaining with anti-2A antibody. Representative images of semi-quantitative RT-PCR with Nrxn AS4 in granule neurons with or without ectopic SLM1 
expression. (B) High magnification views of SLM1 immunoreactivity in Purkinje cell–specific Slm1KO (Slm1cKO) mice. Purkinje cells are marked by transgenic 
expression of EGFP from the Purkinje cell–specific L7 promoter. Bar, 50 µm. (C) Representative images of semi-quantitative RT-PCR with Nrxn AS4 in 
cerebellum from wild-type, Slm1KO, and Slm1cKO mice. (D) Quantitative RT-PCR for Nrxn1 and Nrxn2 AS4 in wild-type, Slm1KO, and Slm1cKO mice (n = 4 
animals per genotype).
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linked considering that Purkinje cell anchoring centers have 
been proposed to instruct the foliation process (Sudarov and 
Joyner, 2007). Specifically, we observed loss of the fissure be-
tween lobules VI and VII in the cerebellar vermis. Whereas the 
primary and secondary fissures flanking lobules VI–VIII form 
during late embryonic development, the separation of lobules 
VI and VII occurs during the first postnatal week (Altman and 
Bayer, 1997). The STAR protein pre-mRNA substrates rele-
vant for this phenotype remain to be identified. Notably, sim-
ilar foliation defects have been reported in knockout mice for 
several other neuronal signaling proteins (Sadakata et al., 2007; 
Lancaster et al., 2011). Definition of the complete alternative 
splicing programs for STAR proteins as well as the dissection of 
cellular phenotypes of SLM1-deficient neurons should provide im-
portant next steps in testing the links between cell type–specific 
alternative splicing programs and neuronal development.
Materials and methods
Antibodies and DNA constructs
Polyclonal antibodies to SAM68, SLM1, and SLM2 were raised in rabbits 
and guinea pigs using the following synthetic peptides (amino acids in 
brackets were added to improve solubility of the peptide and for coupling): 
RGVPPPPTVRGAPTPRAR-[C] (anti-SAM68), VNEDAYDSYAPEEWAT-[KKKC] 
(anti-SLM1), and PRARGVPPTGYRP-[C] (anti-SLM2; Iijima et al., 2011). 
Anti-GFP antibodies were raised in rabbits using recombinant GFP ex-
pressed in Escherichia coli as an antigen (Taniguchi et al., 2007). The fol-
lowing commercially available antibodies were used: mouse anti–-tubulin 
(E7; DSHB), mouse anti-Fox3/NeuN (MAB377; EMD Millipore), rat anti-
HA (clone 3F10; Roche), sheep anti-parvalbumin (R&D Systems), mouse 
anti-calbindin (Swant), goat anti-calretinin (Swant), rabbit anti-VIP (Immuno-
star), mouse anti-cholecystokinin (CCK8; Abcam), goat anti-RORalpha (C-16; 
Santa Cruz Biotechnology, Inc.), rabbit anti-vesicular glutamate transporter 
1 (vGluT1, #1353303; Synaptic Systems), rabbit anti-vesicular glutamate 
transporter 2 (vGluT2, #135403; Synaptic Systems), guinea pig anti-vesicular 
GABA transporter (vGAT, #676780; EMD Millipore), and rabbit anti-2A 
peptide (EMD Millipore).
Somatostatin-positive interneurons were marked in Somatostatin-
IRES-cre mice crossed to tdTomato reporter mice (Madisen et al., 2010; 
Taniguchi et al., 2011).
Expression vectors (pEGFP backbone, CMV promoter) for SAM68, 
SLM1, SLM2, hnRNPA1, hnRNPH, and Nrxn1 AS4 splice reporters were 
described previously (Di Fruscio et al., 1999; Fisette et al., 2010; Iijima 
et al., 2011). The Nrxn2 AS4 splice reporter contains a mouse Nrxn2 ge-
nomic cassette of AS4 from exon 19 to exon 21 containing 500 bp in-
tronic sequence at each splice donor and acceptor site.
RNA isolation and alternative splicing assays
Human embryonic kidney (HEK293 and HEK293T) cells were cultured in 
DMEM (Invitrogen) supplemented with 10% FCS, l-glutamine (2 mM), peni-
cillin, and streptomycin and grown in 5% CO2 at 37°C. For reporter as-
says, cells were cotransfected using Fugene 6 reagent (Roche) with 
expression vectors encoding the splice reporter and RNA-binding proteins. 
RNA was harvested 24–36 h after transfection using Trizol reagent (Invit-
rogen), followed by removal of contaminating DNA using Turbo DNA-free 
(RNase-free DNase; Ambion). 1 µg of total RNA was reverse transcribed 
using random hexamers and ImProm-II (Promega).
For semi-quantitative PCR, DNA fragment intensities were quantified 
by image analyzer (FAS-III; Toyobo) and ImageGauge software (Fujifilm). 
Oligonucleotide primers used for semi-quantitative PCR were described 
previously (Iijima et al., 2011).
Quantitative PCR was performed on a StepOnePlus qPCR system (Ap-
plied Biosystems). Custom and commercial gene expression assays (see 
Table 1) were used with TaqMan Master Mix (Applied Biosystems) and compar-
ative CT method. The mRNA levels were normalized to that of Gapdh mRNA.
Biochemical procedures
Cells or brain tissues were lysed with RIPA buffer (25 mM Tris-HCl, pH 8.0, 
150 mM NaCl, 1% NP-40, 1% deoxycholate, and 0.1% SDS) containing 
Synergistic and differential functions of 
SAM68 and SLM proteins
In a previous study, we reported a dynamic regulation of Nrxn1 
AS4 by SAM68, a closely related alternative splicing factor 
(Iijima et al., 2011). However, expression and function of SAM68 
and SLM1 differ in several fundamental aspects. SAM68 activ-
ity toward Nrxn1 AS4 depends on activation through neuronal 
signaling. Thus, the presence of SAM68 in a cell population is 
not predictive of Nrxn1 isoform choice (Iijima et al., 2011). 
Moreover, SAM68 is broadly expressed across neuronal and 
nonneuronal cells (Richard et al., 2005; Paronetto et al., 2009). 
By contrast, SLM1 exhibits a more restricted expression pat-
tern. Our gain-of-function and loss-of-function studies demon-
strate that SLM1 instructs cell type–specific alternative splicing 
choices. Moreover, our experiments uncover a complex inter-
play between SAM68 and SLM1 activities as the regulation of 
alternative splicing at AS4 differs significantly for Nrxn1, -2, 
and -3 transcripts. While SAM68 and SLM1 synergize in driv-
ing exon skipping at AS4 in Nrxn1, they antagonize each other 
at Nrxn3 AS4 in vivo. We demonstrated that specific sequences 
in the RNA-binding domain of SLM1 are required for regulation 
of Nrxn2 AS4, which is insensitive to SAM68. Finally, our in vitro 
experiments support a model where hetero-oligomerization of 
SAM68 with SLM1 provides one potential mechanism that 
gates substrate specificity of SLM1, and thereby a further mech-
anism for regulation. Interestingly, a recent study by Elliott and 
colleagues demonstrated a splicing regulatory function of SLM2 
toward Nrxn2 that is similar to the function for SLM1 described 
here. Based on a comparison of regional SLM2 expression and 
estimates of Nrxn1 AS4() abundance they suggested that 
SLM2 is the primary regulator of Nrxn1 AS4() in vivo 
(Ehrmann et al., 2013). Considering the largely nonoverlapping 
expression patterns of SLM1 and SLM2 across cell populations 
as well as our global and cell type–specific knockout analysis of 
SLM1, we conclude that SLM2 is not the sole regulator of Nrxn1 
AS4 in vivo. Instead, we demonstrate with gain-of-function and 
loss-of-function experiments that SLM1 as well as SAM68 
have major, cell type–specific contributions to Nrxn alternative 
splice variant choices in vivo.
Functional relevance of SLM1 in the 
developing nervous system
Neuronal subtype–specific alternative splicing patterns might 
contribute to the unique functional properties of neuronal cell 
populations. Such a mechanism is particularly attractive for 
polymorphic receptor families such as the neurexins that may 
contribute to specific cellular interactions or specific synaptic 
functions (Missler and Südhof, 1998; Boucard et al., 2005; Chih 
et al., 2006; Graf et al., 2006; de Wit et al., 2009; Baudouin and 
Scheiffele, 2010; Futai et al., 2013). Further work will be needed 
to understand the respective contributions of SAM68 and SLM 
proteins in shaping cell type–specific neurexin isoform con-
tents. Moreover, neurexins are likely to be only one of many 
targets for SLM-dependent alternative splicing regulation. Our 
analysis of Sam68:Slm1DKO animals uncovered the presence of 
ectopic Purkinje cells and defects in the foliation of the cerebel-
lar cortex. These two aspects of the phenotype are most likely 
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Knockout mice
Sam68KO mice were provided by S. Richard (McGill University, Mon-
treal, Quebec, Canada; Richard et al., 2005). An Slm1 conditional al-
lele was generated by homologous recombination in mouse embryonic 
stem cells. In brief, a genomic DNA fragment containing exon 2 (ENS-
MUSE00000314986) was flanked by a LoxP site and a FRT-PGK- 
neo-LoxP cassette encoding neomycin phosphotransferase under control 
of the phosphoglycerate kinase 1 promoter. The targeting vector was 
electroporated into 129SvEvTac embryonic stem cells. Homologous re-
combination in G-418–resistant clones was confirmed and selected 
cells were blastocyst injected. Chimeric animals were crossed with 
ROSA-26 Flpe mice to remove PGK-neo sequences through Frt/Flp-me-
diated excision. The Slm1flox/+ mice were crossed with CMVcre deleter 
mice (Schwenk et al., 1995) to generate a germline deletion of Kh-
drbs2. Conditional ablation of Khdrbs2 in Purkinje was done using Pcp-
2cre knock-in mice (Saito et al., 2005). The Slm1flox allele was detected 
by PCR using primers 5-CCCTGAGAGGCTGAGGTTAG-3 (Lox gtF), 
5-AAGTGCAGTGCCACAAAATG-3 (Lox gtR), 5-CCACAAGCCATA-
AAATTGAGC-3 (Frt gtF), and 5-GCCAACAACATTTGGCTAGAG-3 
(Frt gtR).
Sam68:Slm1DKO mice were generated by intercrossing of the indi-
vidual mutant mice. The resulting homozygous mutant mice were viable.
Statistical analysis
Pairwise comparisons were performed using Student’s t test. For multiple 
comparisons, analysis of variance (ANOVA) followed by Bonferroni or Dun-
nett test was used. Data are represented as the mean ± SEM. Significance is 
indicated as follows: ***, P < 0.001; **, P < 0.01; *, P < 0.05.
Online supplemental material
Fig. S1 shows Western blot and immunohistochemical data on region-specific 
expression of SAM68 and SLM proteins. Fig. S2 shows high-resolution 
views of neuronal cell type–specific expression of SAM68 and SLM pro-
teins in mouse hippocampus. Fig. S3 illustrates targeting strategy for gen-
eration of Slm1KO mice and morphological analysis. Fig. S4 shows Purkinje 
cell–specific Slm1KO mice. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.201310136/DC1.
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Figure S1.  Region-specific expression of SAM68 and SAM68-like mammalian proteins in mouse brain. (A) Western blot analysis of SAM68, SLM1, and 
SLM2 protein expression across mouse brain regions with isoform-specific antibodies. (B) Immunohistochemical detection of SLM1 and SLM2 with isoform-
specific antibodies in coronal sections of adult mouse brain. A rostral section across cortex (Cx), hippocampus (Hp), thalamus (Th), and hypothalamus (Hy) 
is shown. Bar, 1 mm. (C) Immunohistochemical detection of SAM68, SLM1, and SLM2 with isoform-specific antibodies in the developing mouse brain (post-
natal day 8; Str, striatum; Bs, brainstem; Md, midbrain; Cb, cerebellum). Bar, 1 mm.
JCB S2 
Figure S2.  Neuronal cell type–specific expression of SAM68 and SAM68-like mammalian proteins in mouse hippocampus. (A) Co-immunohistostaining 
with anti-SLM1 (red) and SLM2 (green) antibodies in mouse hippocampal regions. Bar, 1 mm. (B) SLM1 (red) and SLM2 (green) are expressed in different 
interneuron populations in striatum radiatum. Interneurons were detected by co-immunostaining with anti-NeuN (blue). Bar, 50 µm. (C) Triple staining of 
anti-SLM antibodies (red) with interneuron markers anti-calbindin antidody (blue) and anti-cholecystokinin antibody (red). SLM1 was highly expressed in 
the calbindin/cholecystokinin double-positive interneurons. Bar, 10 µm.
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Figure S3.  Generation of Slm1KO mice. (A) Targeting strategy for conditional ablation of Slm1 in mice. The Khdrbs2 gene encoding SLM1 was modified 
by insertion of loxP sites flanking exon 2 (blue) and targeted ES cells isolated based on G418 resistance conferred by the PGKneo cassette. PGKneo was 
subsequently excised by breeding to ROSA-26 Flpe mice. The translational start codon is encoded in exon 1, after removal of exon 2, splicing into exon 
3 results in a shift in translational reading frame. The RNA-binding KH domain of SLM1 is encoded in exons 3, 4, and 5. (B) Normal morphology of dentate 
gyrus region in the hippocampus of Sam68/Slm1DKO cerebellum. Overall morphology of granule cells in dentate gyrus was visualized by immunostaining 
with anti-calbindin antibody. Bar, 1 mm. (C) Normal synaptic inputs into Purkinje cells in Sam68/Slm1DKO cerebellum. Synapses from parallel fibers are de-
tected by vGluT1, a marker for excitatory presynapses. Synapses from climbing fibers are detected by vGluT1, a marker for excitatory presynapses. Syn-
apses from interneurons in molecular layer are detected by vGAT, a marker for inhibitory presynapses. Purkinje cells were marked by anti-calbindin 
antibody. Bar, 50 µm.
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Figure S4.  Generation of Purkinje cell–specific Slm1 knockout (Slm1cKO) mice. Low views of para-sagittal sections of cerebellum demonstrates anti-SLM1 
immunoreactivity in cerebellar Purkinje cells, which is specifically lost in Slm1cKO. Purkinje cells are marked by transgenic expression of EGFP from the Pur-
kinje cell–specific L7-promoter. Bar, 1 mm.
